Search filters

List of works by Johannes Schetelig

188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation

scientific article published on 7 December 2009

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome ⬇️

scientific article published on October 1, 2001

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

scientific article published on 20 October 2020

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

scientific article published on 30 December 2003

Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation

scientific article published on 22 January 2016

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

scientific article

After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.

scientific article published in May 2005

Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia

scientific article published on 01 May 2007

Allele-Level Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations

scientific article published on 04 December 2018

Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features

scientific article published on 30 August 2016

Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.

scientific article published on 6 November 2015

Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study

scientific article published on 16 August 2020

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

scientific article published in September 2017

Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine

scientific article

Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis

scientific article published on 18 August 2008

Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema

scientific article published on 17 June 2014

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

scientific article published on 28 March 2017

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

scientific article

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease

scientific article published on March 2002

An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants.

scientific article published on 9 January 2018

Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial

scientific article published on 12 March 2018

Antiviral treatment of Influenza A (H1N1-09) guided by molecular resistance testing in aplasia after allo-SCT ⬇️

scientific article published on January 17, 2011

Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors ⬇️

scientific article published on December 16, 2011

Assessment of the T cell receptor repertoire in long-term platelet donors by next generation sequencing.

scientific article published on 8 March 2017

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

scientific article published in PLoS ONE

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

scientific article published on 2 September 2011

Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party o

scientific article published on 17 June 2017

Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT).

scientific article published on 07 June 2017

Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy

scientific article published in January 2007

Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient

scientific article published on 02 May 2007

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial.

scientific article published on 18 August 2015

Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation

scientific article published on 01 April 2012

Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation

scientific article published on 19 July 2018

Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome

scientific article published on 18 September 2019

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & I

scientific article published on 19 December 2014

Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects

scholarly article by Daniel Fuerst et al published September 2018 in Haematologica

Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection

scientific article published in April 2001

Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study

scientific article published on 23 May 2011

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

scientific article published on 08 September 2021

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor

scientific article published on 21 June 2018

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

scientific article published on 04 June 2020

Donor T-cell responses and disease progression patterns of multiple myeloma

article

Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient

scientific article published on 28 March 2017

Dose‐reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis ⬇️

scientific article published on October 1, 2001

Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation.

scientific article published on 11 January 2016

Dynamics of epigenetic age following hematopoietic stem cell transplantation

scientific article published on 26 May 2017

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

scientific article published on 21 January 2019

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia

scientific article published on 14 August 2019

Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial

scientific article published on 05 April 2012

Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia

scientific article published on 07 May 2013

Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial

scientific article published on 05 April 2018

Erratum to: "Reduced-Intensity Conditioning Combined with 188Rhenium Radioimmunotherapy before Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: The Role of in Vivo T Cell Depletion" [Biol Blood Marr

scientific article published on 06 January 2017

Estimation of German KIR Allele Group Haplotype Frequencies

scientific article published on 12 March 2020

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

scientific article

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

scientific article published on 01 April 2020

Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot study

scientific article published on 3 November 2015

Frequency of lethal central nervous system neurotoxicity in patients undergoing allogeneic stem cell transplantation: a retrospective registry analysis

scientific article published on 06 November 2019

Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia

scientific article published in September 2008

Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology

scientific article published on 16 November 2016

Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation

scientific article published on 09 June 2010

Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial

scientific article published in January 2009

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy

scientific article published on 11 February 2011

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

scientific article published in December 2014

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium.

scientific article published on 25 November 2011

High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial

scientific article published on 29 April 2013

High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies

scientific article published on 11 July 2018

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

scientific article published on 07 November 2019

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

scientific article published on 04 May 2018

Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

scientific article published on 02 October 2020

Immunogenetics in stem cell donor registry work: The DKMS example (Part 1)

scientific article published on 06 January 2020

Immunogenetics in stem cell donor registry work: The DKMS example (Part 2)

scientific article published on 07 February 2020

Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia

scientific article published on 21 February 2013

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

scientific article published on 16 May 2017

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

scientific article published on 16 November 2006

Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

scientific article published on 31 August 2006

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicine for acute myeloid leukemia in elderly patients

scientific article

KIR Genotyping Data of More Than 3 Million Individuals Are Available for Global Unrelated Stem Cell Donor Searches (Comment to: Weisdorf D, Cooley S, Wang T, et al. KIR donor selection: feasibility in identifying better donors. Biol Blood Marrow Tra

scientific article published on 21 September 2018

Karyotype complexity and prognosis in acute myeloid leukemia

scientific article published on 15 January 2016

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia

scientific article published on 01 July 2002

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

scientific article published on 20 December 2018

Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus

scientific article published on 21 June 2007

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

scientific article published on 17 May 2017

Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

scientific article published in November 2003

Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised

scientific article published on 14 March 2018

Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation

scientific article

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

scientific article published on 07 February 2019

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.

scientific article

Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation

scientific article published on 26 July 2016

Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia

scientific article published on 12 June 2020

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation

scientific article published on 18 September 2012

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

scientific article

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells

scientific article published on 24 August 2017

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group

scientific article published on 2 September 2008

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

scientific article published on 12 November 2018

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

scientific article

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL).

scientific article

Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas

scientific article published on 28 September 2019

Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation

scientific article published on November 2009

Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia ⬇️

scientific article published on October 16, 2012

Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusion

scientific article published on 22 January 2016

Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients

scientific article published on 30 March 2015

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

scientific article published on 27 February 2014

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.

scientific article published on 31 July 2012

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

scientific article published on 20 March 2014

Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Pa

scientific article published on 7 May 2015

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT.

scientific article published on 18 December 2017

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial).

scientific article

Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.

scientific article published on 12 February 2018

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation

scientific article published on 03 July 2019

Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors

scientific article

Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase

scientific article published on 02 February 2017

Proinflammatory human 6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease

scientific article published on 28 March 2014

Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

scientific article published on 03 May 2011

Radioimmunotherapy in Combination with Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Multiple Myeloma

scientific article published on 12 November 2019

Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).

scientific article

Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells

scientific article published on 01 January 2005

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation

scientific article published on 01 June 2012

Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation

scientific article published on 30 November 2012

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

scientific article

Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning

scientific article published on 29 August 2019

Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia

scientific article

Reduced-Intensity Conditioning Combined with (188)Rhenium Radioimmunotherapy before Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: The Role of In Vivo T Cell Depletion

scientific article published on 19 May 2015

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

scientific article

Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis

scientific article

Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

scientific article published on 24 July 2018

Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation

scientific article published on 22 February 2017

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

scientific article published on 23 January 2017

Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation

scientific article published on 07 November 2018

Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial

scientific article published on 07 October 2020

Simultaneous determination of clofarabine and cytarabine in human plasma by LC-MS/MS.

scientific article published in April 2016

Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.

scientific article published in August 2010

Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes

scientific article published on 11 October 2020

Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS

scientific article published on 20 November 2020

T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation

scientific article

T-cell receptor-α repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing

scholarly article by Cornelia S Link-Rachner et al published March 2019 in Haematologica

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

scientific article

Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation

scientific article

The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controls

scientific article published on 20 January 2017

The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation

scientific article published on 24 August 2020

The clinical mutatome of core binding factor leukemia

scientific article published on 02 January 2020

The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index ⬇️

scientific article published on June 25, 2011

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

scientific article published on 8 May 2013

The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the Prospective PETAML Trial

scientific article published on 29 August 2019

Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation

scientific article published on 24 June 2009

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

scientific article published on 29 September 2008

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, ph

scientific article published on 09 October 2019

Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome

scientific article published on 3 July 2013

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 21 May 2018

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial

scientific article published in May 2018

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

scientific article

Paulina is supported by:

About Paulina

Help